Last reviewed · How we verify

NCT06733896

SCM Muscle Released in Patients with Cervicogenic Headache

Completed NA Last updated 11 February 2025
What this trial tests

NA trial testing trigger point pressure in Cervicogenic Headache in 52 participants. Completed in 10 February 2025.

Timeline
1 January 2025
Primary endpoint
10 February 2025
10 February 2025

Quick facts

Lead sponsorAl-Zaytoonah University of Jordan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment52
Start date1 January 2025
Primary completion10 February 2025
Estimated completion10 February 2025
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

Al-Zaytoonah University of Jordan

Who can join

Adults 25 to 50, any sex, with Cervicogenic Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sternocleidomastoid syndrome is often characterized by referred pain in other areas. Like all muscles, the SCM can develop tight, and non-contracting bands called trigger points that can refer pain elsewhere. For the SCM, the trigger point referral areas are the eye and forehead, the back of the head (occiput), front of the neck, cheek, and side of the head. Trigger points can be treated by direct manual massage, dry needling, or platelet-poor plasma injection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cervicogenic Headache

Currently open trials in the same condition.

Other Al-Zaytoonah University of Jordan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06733896.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing